EGFR L858R Mutation May Go Undetected Because of P848L in cis Mutation

被引：6
|
作者：
Santamaria, Inigo [1 ]
Menendez, Sofia T.
Balbin, Milagros
机构：
[1] Hosp Univ Cent Asturias, Oviedo, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 26期
关键词：
CELL LUNG-CANCER; RARE;
D O I：
10.1200/JCO.2012.47.3512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E420 / E421
页数：2
相关论文
共 50 条
  • [11] EGFR L858R mutation as a possible target for individual-independent immunotherapy in Chinese population.
    Chen, Yu
    Hao, Shiguang
    Guo, Zeng-qing
    Lin, Jing
    Chen, Li-zhu
    Chen, Ling
    Yu, Jia-mi
    Chen, Gang
    Zheng, Xiong-wei
    Yi, Yuting
    Guan, Yan-Fang
    Xia, Xuefeng
    Yi, Xin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [12] L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer
    Sasaki, Hidefumi
    Endo, Katsuhiko
    Takada, Minoru
    Kawahara, Masaaki
    Kitahara, Naoto
    Tanaka, Hisaichi
    Okumura, Meinoshin
    Matsumura, Akihide
    Iuchi, Keiji
    Kawaguchi, Tomoya
    Yukiue, Haruhiro
    Kobayashi, Yoshihiro
    Yano, Motoki
    Fujii, Yoshitaka
    [J]. LUNG CANCER, 2006, 54 (01) : 103 - 108
  • [13] EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity
    Yang, Yong
    Yang, Yang
    Zhou, Xiao
    Song, Xiao
    Liu, Ming
    He, Wenxin
    Wang, Hao
    Wu, Chunyan
    Fei, Ke
    Jiang, Gening
    [J]. LUNG CANCER, 2015, 87 (03) : 272 - 277
  • [14] Neoantigen screening identifies EGFR L858R mutation immunogenicity in 1862 Chinese NSCLC patients.
    Lin, Jin
    Chen, Yu
    Chen, Gang
    Jun, Liu
    Hao, Shiguang
    Xiong, Jia-ni
    Lan, Bin
    Xu, Yaping
    Guan, Yan-Fang
    Guo, Zengqing
    Chen, Lin
    Chen, Li-zhu
    Xia, Xuefeng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [15] Comparison of clinicopathologic characteristics between patients with EGFR exon 19 deletion and EGFR L858R mutation in lung cancer
    Chen, Zhen
    Zhang, Jing
    Huang, Ke
    Shen, Qian
    Teng, Xiaodong
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (09): : 4644 - 4649
  • [16] Aumolertinib: effective treatment for asymptomatic pulmonary giant cell carcinoma with EGFR L858R mutation - a case report
    Yang, Wenxing
    Yang, Ze
    Wang, Kaiqiang
    Zhu, Peiquan
    Pu, Jiangtao
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [17] Mutant allele frequency predicts the efficacy of EGFR-TKIs in lung adenocarcinoma harboring the L858R mutation
    Ono, A.
    Kenmotsu, H.
    Watanabe, M.
    Serizawa, M.
    Mori, K.
    Imai, H.
    Taira, T.
    Naito, T.
    Murakami, H.
    Nakajima, T.
    Ohde, Y.
    Endo, M.
    Yamamoto, N.
    Koh, Y.
    Takahashi, T.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (10) : 1948 - 1953
  • [18] The L858R mutation of the EGFR gene might be associated with smoking in non-small cell lung cancer
    Buyru, Nur
    Baykara, Onur
    Tansarikaya, Merve
    Ulutin, Turgut
    [J]. CANCER RESEARCH, 2011, 71
  • [19] Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the EGFR L858R Mutation: A Brief Report
    Chen, Yu-Qing
    Li, Yu-Fa
    Zhang, Chan-Yuan
    Zhang, Shi-Ling
    Lv, Zhi-Yi
    Dong, Song
    Chen, Hua -Jun
    Zhang, Xu-Chao
    Wu, Yi-Long
    Yang, Jin-Ji
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (12):
  • [20] The Performance of an L858R Mutation Specific EGFR Antibody in Non-Small Cell Lung Cancer Specimens
    Kyshtoobayeva, A.
    Bloom, K. J.
    [J]. MODERN PATHOLOGY, 2012, 25 : 480A - 481A
12345